Also trades as: NGLFINE.NS (NSE) · $vol 1M
NGLFINE.BO BSE
NGL Fine-Chem Limited
1W: +1.0%
1M: +8.9%
3M: -10.2%
YTD: +31.2%
1Y: +118.6%
3Y: +51.4%
₹2,905.00 ($30.18)
-20.50 (-0.70%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$5.0B
+36.0% ▲
5Y CAGR: +14.2%
Gross Profit
$1.8B
-5.1% ▼
5Y CAGR: +2.9%
Operating Income
$531M
+136.8% ▲
5Y CAGR: -6.9%
Net Income
$481M
+127.8% ▲
5Y CAGR: -3.2%
EPS (Diluted)
$77.90
+127.8% ▲
5Y CAGR: -3.2%
EBITDA
$874M
+158.1% ▲
5Y CAGR: -0.2%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $3.2B | $2.8B | $3.4B | $3.7B | $5.0B |
| YoY Growth | +23.1% | -12.4% | +21.8% | +8.7% | +36.0% |
| Cost of Revenue | $1.5B | $1.4B | $1.7B | $1.8B | $3.2B |
| Gross Profit | $1.7B | $1.4B | $1.7B | $1.9B | $1.8B |
| Gross Margin | 52.2% | 49.5% | 50.1% | 50.5% | 35.2% |
| R&D Expenses | $17M | $24M | $47M | $50M | $0 |
| SG&A Expenses | $206M | $209M | $218M | $577M | $1.2B |
| Operating Expenses | $1.1B | $233M | $1.3B | $555M | $1.2B |
| Operating Income | $578M | $237M | $421M | $224M | $531M |
| Operating Margin | 18.2% | 8.5% | 12.4% | 6.1% | 10.6% |
| Interest Expense | $19M | $18M | $18M | $23M | $45M |
| Income Before Tax | $666M | $274M | $544M | $277M | $634M |
| Tax Expense | $167M | $69M | $131M | $66M | $152M |
| Net Income | $499M | $205M | $413M | $211M | $481M |
| Net Margin | 15.7% | 7.4% | 12.2% | 5.7% | 9.6% |
| EPS (Diluted) | $80.77 | $33.18 | $66.88 | $34.19 | $77.90 |
| EBITDA | $789M | $405M | $679M | $339M | $874M |
| Shares Outstanding | 6M | 6M | 6M | 6M | 6M |